Implementing Lung Cancer Screening Using Low-Dose Computed Tomography: Recommendations From an Expert Panel.

Published

Journal Article

PURPOSE: In December 2013, the US Preventive Services Task Force issued a final B-level recommendation indicating that individuals between the ages of 55 and 80 years who have a 30-pack-year smoking history and have smoked within the past 15 years should receive annual low-dose computed tomography (CT) lung cancer screening. We convened a multidisciplinary panel of experts to create practical guidance for efficiently implementing effective CT lung cancer screening programs. METHODS: The lung cancer screening panel included 12 members, representing a broad range of stakeholders. The panel discussed clinical and system issues related to the implementation of CT lung cancer screening and developed recommendations for implementing CT lung cancer screening programs. RESULTS: The panel identified five main goals that must be achieved to maximize the efficiency and effectiveness of implementing CT lung cancer screening: one, accurately identify individuals eligible for screening; two, provide access to screening at qualified facilities for eligible individuals; three, ensure appropriate follow-up for positive and negative screening results; four, promote continuous quality improvement of screening programs and downstream care; and five, provide smoking cessation support for all current smokers. The panel proposed a series of stakeholder-specific recommendations for achieving these goals. CONCLUSION: Implementation of effective and efficient population-based CT lung cancer screening will require involvement and coordination of stakeholders across the health care system to address the data and infrastructural needs that were identified.

Full Text

Duke Authors

Cited Authors

  • Ramsey, SD; Malin, JL; Goulart, B; Ambrose, LF; Kanne, JP; McKee, AB; Reed, SD; Schwartz, JS; Sullivan, SD

Published Date

  • January 2015

Published In

Volume / Issue

  • 11 / 1

Start / End Page

  • e44 - e49

PubMed ID

  • 25491043

Pubmed Central ID

  • 25491043

Electronic International Standard Serial Number (EISSN)

  • 1935-469X

Digital Object Identifier (DOI)

  • 10.1200/JOP.2014.001528

Language

  • eng

Conference Location

  • United States